Simvastatin Structural Formula (Bb0802ae 207d 40c7 8e80 4dcc8ebe94e2 01)
Simvastatin
Product Images NDC 66116-316
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 66116-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Bb0802ae 207d 40c7 8e80 4dcc8ebe94e2 02)
This appears to be a table presenting data related to major coronary events and their incidence among patients with different characteristics, such as diabetes, age, cholesterol levels, and gender. The table compares the incidence of these events in patients taking simvastatin versus those taking a placebo. However, without a proper context or explanation, it is difficult to draw any meaningful conclusions from this text.*
Simvastatin Tablet Usp 20mg (Bb0802ae 207d 40c7 8e80 4dcc8ebe94e2 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
